MindBio Therapeutics Archives

Psychedelics News

MindBio Therapeutics

Breaking News

26 Feb 2024

MindBio Therapeutics Announces Positive Depression Data from World-First Phase 2A Take-Home Microdosing Trial

MindBio Therapeutics has announced groundbreaking results from a Phase 2a clinical trial involving the take-home microdosing of MB22001 for treating depression. This world-first trial showcased a significant decrease in depression...

By Microdose NewsDesk

Breaking News

24 May 2023

MindBio Therapeutics Receives Approval for First-Ever Phase 2 Trial of LSD Microdosing

MindBio Therapeutics Ethics Approval for Landmark World First Phase 2 Clinical Trial of Take-Home LSD-Microdosing for Major Depressive Disorder...

By Microdose NewsDesk

Events

18 Nov 2022

Wonderland 2022 Review: MindBio Therapeutics

At Wonderland's Microdosing with LSD panel, Justin Hanka and Dr....

By Microdose

Events

26 Oct 2022

Microdose Announces MindBio Therapeutics as Wonderland 2022 Platinum Sponsor

MindBio Therapeutics will be presenting at Wonderland 2022 as a key Platinum Sponsor...

By Microdose

Join Our Newsletter for Exclusive Updates, Stories, and More

Industry

11 Jul 2022

In Psychedelic Investing, Long-Term Thinking Is Key

In the fast-growing field of psychedelic medicine, long-term investing is key....

By Microdose

Don’t Miss

9 May 2022

News You Might Have Missed: May 9th, 2022

Welcome to the News You Might Have Missed, a weekly roundup of psychedelic industry news to help you catch up and stay informed....

By Microdose NewsDesk

Events

7 May 2022

Plant Medicine Week 2022: Microdosing Clinical Trials

Justin Hanka from MindBio Therapeutics was one of the keynote speakers at Plant Medicine Week, and his company is positioning itself as a leader in this LSD renaissance....

By Microdose

Industry

5 May 2022

MindBio Therapeutics Completes World’s First Microdosing Trial

MindBio Therapeutics Announces Completion of World First Phase 1 Microdosing Clinical Trial...

By Microdose NewsDesk

Industry

18 Mar 2022

A Closer Look at MindBio Therapeutics

So while ATAI and MindMed draw more eyeballs and investors to the sector, smaller firms like MindBio have the chance to do their early work while the wider industry grows...

By Microdose

Follow us on social

Latest News

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Two New Studies Are Rewriting the Rules of Psychedelic Drug Development

Professional Training in Psychedelic Medicine

Psychedelic medicine is reshaping the future of mental health care. From the power of microdosing LSD to the promise of MDMA in PTSD, the world of medical psychedelics offers transformative possibilities. Our comprehensive, CE-accredited course provides you with the knowledge and understanding you need to tap into this groundbreaking field.

WordPress Ads

No Result

View All Result